Literature DB >> 7535295

Counterstained enhancement of TaqI resistant sites after distamycin A/diamidinophenylindole treatment.

R A Conte1, R S Verma.   

Abstract

Numerous selective and differential staining techniques have been used to investigate the hierarchical organisation of the human genome. This investigation demonstrates the unique characteristics that are produced on fixed human chromosomes when sequential procedures involving restriction endonuclease TaqI. distamycin A (DA) and 4',6-diamidino-2-phenylindole (DAPI) are employed. TaqI produces extensive gaps in the heterochromatic regions associated with satellite II and III DNAs of human chromosomes 1, 9, 15, 16 and Y. DA/DAPI selectively highlights, as brightly fluorescent C-bands, the heterochromatin associated with the alpha, beta, satellite II and III DNAs of these chromosomes. When DA and DAPI are used on chromosomes before TaqI digestion, and then stained with Giemsa, the centromeric regions appear to be more resistant, producing a distinct C-banding pattern and gaps in the heterochromatin regions. Sequential use of the DA/DAPI technique after TaqI treatment produces a bright fluorescence on the remaining pericentromeric regions of chromosomes 1, 9, 16 and Y, which also displayed a cytochemically unique banding pattern. This approach has produced specific enhanced chromosomal bands, which may serve as tools to characterize genomic heterochromatin at a fundamental level.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7535295     DOI: 10.1007/bf00269574

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  15 in total

1.  Deciphering the fluorescent variability of human genomic heterochromatin by DA/DAPI technique.

Authors:  R S Verma; R A Conte; S Luke; V Sindwani; M J Macera
Journal:  Clin Genet       Date:  1992-11       Impact factor: 4.438

Review 2.  Nonintercalating DNA-binding ligands: specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material.

Authors:  C Zimmer; U Wähnert
Journal:  Prog Biophys Mol Biol       Date:  1986       Impact factor: 3.667

3.  Human satellite III DNA: genomic location and sequence homogeneity of the TaqI-deficient polymorphic sequences.

Authors:  J C Fowler; L A Burgoyne; E G Baker; M L Ringenbergs; D F Callen
Journal:  Chromosoma       Date:  1989-10       Impact factor: 4.316

4.  The structure of an oligo(dA).oligo(dT) tract and its biological implications.

Authors:  H C Nelson; J T Finch; B F Luisi; A Klug
Journal:  Nature       Date:  1987 Nov 19-25       Impact factor: 49.962

5.  Simultaneous fluorescent staining of R bands and specific heterochromatic regions (DA-DAPI bands) in human chromosomes.

Authors:  D Schweizer
Journal:  Cytogenet Cell Genet       Date:  1980

6.  Reversible bending and helix geometry in a B-DNA dodecamer: CGCGAATTBrCGCG.

Authors:  A V Fratini; M L Kopka; H R Drew; R E Dickerson
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

7.  Molecular topography of the secondary constriction region (qh) of human chromosome 9 with an unusual euchromatic band.

Authors:  R S Verma; S Luke; J P Brennan; T Mathews; R A Conte; M J Macera
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

8.  Highly conserved repetitive DNA sequences are present at human centromeres.

Authors:  D L Grady; R L Ratliff; D L Robinson; E C McCanlies; J Meyne; R K Moyzis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

9.  Structural characterization of a 2:1 distamycin A.d(CGCAAATTGGC) complex by two-dimensional NMR.

Authors:  J G Pelton; D E Wemmer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

10.  Mechanisms of distamycin A/DAPI chromosome staining. I. Competition binding effects of nonintercalative DNA groove-binding agents in situ and in vitro.

Authors:  G Burckhardt; H Votavova; M Jantsch; C Zimmer; J W Lown; D Schweizer
Journal:  Cytogenet Cell Genet       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.